These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22311530)

  • 21. "Frontal systems" behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependency.
    Marquine MJ; Iudicello JE; Morgan EE; Brown GG; Letendre SL; Ellis RJ; Deutsch R; Woods SP; Grant I; Heaton RK;
    Psychiatry Res; 2014 Jan; 215(1):208-16. PubMed ID: 24290100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Executive dysfunction in patients with spinocerebellar ataxia type 3.
    Tamura I; Takei A; Hamada S; Soma H; Nonaka M; Homma S; Moriwaka F
    J Neurol; 2018 Jul; 265(7):1563-1572. PubMed ID: 29725839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurocognitive Profiles of Methamphetamine Users: Comparison of Those With or Without Concomitant Ketamine Use.
    Chen YC; Wang LJ; Lin SK; Chen CK
    Subst Use Misuse; 2015; 50(14):1778-85. PubMed ID: 26625283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Verbal learning impairment in adolescents with methamphetamine use disorder: a cross-sectional study.
    Basedow LA; Kuitunen-Paul S; Wiedmann MF; Ehrlich S; Roessner V; Golub Y
    BMC Psychiatry; 2021 Mar; 21(1):166. PubMed ID: 33765981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute, low-dose methamphetamine administration improves attention/information processing speed and working memory in methamphetamine-dependent individuals displaying poorer cognitive performance at baseline.
    Mahoney JJ; Jackson BJ; Kalechstein AD; De La Garza R; Newton TF
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):459-65. PubMed ID: 21122811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mephedrone (4-methylmethcathinone) and d-methamphetamine improve visuospatial associative memory, but not spatial working memory, in rhesus macaques.
    Wright MJ; Vandewater SA; Angrish D; Dickerson TJ; Taffe MA
    Br J Pharmacol; 2012 Nov; 167(6):1342-52. PubMed ID: 22748013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risks of psychosis in methamphetamine users: cross-sectional study in Thailand.
    Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Sribanditmongkol P; Junkuy A; Srisurapanont M
    BMJ Open; 2019 Oct; 9(10):e032711. PubMed ID: 31615802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of methamphetamine abuse and serotonin transporter gene variants on aggression and emotion-processing neurocircuitry.
    Payer DE; Nurmi EL; Wilson SA; McCracken JT; London ED
    Transl Psychiatry; 2012 Feb; 2(2):e80. PubMed ID: 22832817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognitive deficits are associated with unemployment in chronic methamphetamine users.
    Weber E; Blackstone K; Iudicello JE; Morgan EE; Grant I; Moore DJ; Woods SP;
    Drug Alcohol Depend; 2012 Sep; 125(1-2):146-53. PubMed ID: 22560676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Episodic memory retrieval in adolescents with and without developmental language disorder (DLD).
    Lee JC
    Int J Lang Commun Disord; 2018 Mar; 53(2):271-281. PubMed ID: 29119716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Withdrawal symptoms in abstinent methamphetamine-dependent subjects.
    Zorick T; Nestor L; Miotto K; Sugar C; Hellemann G; Scanlon G; Rawson R; London ED
    Addiction; 2010 Oct; 105(10):1809-18. PubMed ID: 20840201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Deficits in memory retrieval: an argument in favor of frontal subcortical dysfunction in depression].
    Fossati P; Deweer B; Raoux N; Allilaire JF
    Encephale; 1995; 21(4):295-305. PubMed ID: 7588169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute exercise ameliorates craving and inhibitory deficits in methamphetamine: An ERP study.
    Wang D; Zhou C; Chang YK
    Physiol Behav; 2015 Aug; 147():38-46. PubMed ID: 25846839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P300 event-related potential in abstinent methamphetamine-dependent patients.
    Haifeng J; Wenxu Z; Hong C; Chuanwei L; Jiang D; Haiming S; Zhikang C; Din X; Jijun W; Min Z
    Physiol Behav; 2015 Oct; 149():142-8. PubMed ID: 26051625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders.
    Temmingh HS; van den Brink W; Howells F; Sibeko G; Stein DJ
    J Dual Diagn; 2020; 16(2):208-217. PubMed ID: 31984872
    [No Abstract]   [Full Text] [Related]  

  • 36. Social-cognitive difficulties in former users of methamphetamine.
    Henry JD; Mazur M; Rendell PG
    Br J Clin Psychol; 2009 Sep; 48(Pt 3):323-7. PubMed ID: 19397848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Episodic Memory Impairment in Parkinson's Disease: Disentangling the Role of Encoding and Retrieval.
    Siquier A; Andrés P
    J Int Neuropsychol Soc; 2021 Mar; 27(3):261-269. PubMed ID: 32967754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive deficits among methamphetamine users with attention deficit hyperactivity disorder symptomatology.
    Sim T; Simon SL; Domier CP; Richardson K; Rawson RA; Ling W
    J Addict Dis; 2002; 21(1):75-89. PubMed ID: 11831502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychological deficits in adolescent methamphetamine abusers.
    King G; Alicata D; Cloak C; Chang L
    Psychopharmacology (Berl); 2010 Oct; 212(2):243-9. PubMed ID: 20640405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methamphetamine users show greater than normal age-related cortical gray matter loss.
    Nakama H; Chang L; Fein G; Shimotsu R; Jiang CS; Ernst T
    Addiction; 2011 Aug; 106(8):1474-83. PubMed ID: 21438934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.